• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ CT/GC/TV; TRICHOMONAS VAGINALIS NUCLEIC ACID AMPLIFICATION TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ CT/GC/TV; TRICHOMONAS VAGINALIS NUCLEIC ACID AMPLIFICATION TEST SYSTEM Back to Search Results
Model Number 442970
Device Problem False Negative Result (1225)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/14/2022
Event Type  malfunction  
Manufacturer Narrative
A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.
 
Event Description
It was reported that while using bd max¿ ct/gc/tv a false negative result was obtained by the laboratory personnel.A repeat test was used to confirm the results.There was no indication that results were reported out and there was no report of patient impact.The following information was provided by the initial reporter: the result was given out negative by the bd max.Result of bd max was not trusted and customer trusted the curve more - result was given out positive.
 
Manufacturer Narrative
H6: investigation: the complaint investigation for false negative result when using the bd max ct/gc/tv (ref.(b)(4)) lot 1340818 was performed by the review of the manufacturing records, customer¿s data analysis and verification of complaints history.Review of the manufacturing records of bd max ct/gc/tv indicated that the lot was manufactured according to specifications and met performance requirements.Customer reported one sample which initially tested negative (run 1019 a4) with strong amplification of the chlamydia trachomatis target but tested positive when repeated from the same sbt in run 1021 b4 with strong amplification and a ct sdpa value earlier than 15.Customer provided these two run files for investigation.Manual pcr curve adjudication of the sample revealed a strong positive result in run 1019 position a4.However, the result reported by the bdmax was negative due to the atypical curve behavior.Indeed, a ct sdpa value for that sample was earlier than the minimum cycle threshold required to be considered a valid amplification resulting in a negative result.Clinical study for the bd max¿ ct/gc/tv assay, performed on more than 2600 subjects, showed that positive clinical samples usually obtain ct sdpa values higher than 15.A true positive patient sample with a ct sdpa value this early is atypical.The ¿bd max ct gc tv 58¿ adf was developed to avoid false positive results that can be generated by early noise signal.It is a unique situation where a strong signal, that looks like a true amplification, resulted in a negative result.No reagent issue is suspected.There is no indication of an increase in complaints for false negative result for the bd max ct/gc/tv lot 1340818.The root cause for the false negative results was not identified.Bd cannot confirm the complaint based on the investigation that was executed since the assay results logic perform as expected.Bd did not initiate a corrective and preventive action (capa).Bd apologizes for the inconvenience that this may have caused.Bd quality will continue to monitor for trends.
 
Event Description
It was reported that while using bd max¿ ct/gc/tv a false negative result was obtained by the laboratory personnel.A repeat test was used to confirm the results.There was no indication that results were reported out and there was no report of patient impact.The following information was provided by the initial reporter: "the result was given out negative by the bd max.Result of bd max was not trusted and customer trusted the curve more - result was given out positive".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX¿ CT/GC/TV
Type of Device
TRICHOMONAS VAGINALIS NUCLEIC ACID AMPLIFICATION TEST SYSTEM
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer (Section G)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14350089
MDR Text Key299887799
Report Number3007420875-2022-00022
Device Sequence Number1
Product Code OUY
UDI-Device Identifier00382904429706
UDI-Public00382904429706
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K151589
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date11/22/2022
Device Model Number442970
Device Catalogue Number442970
Device Lot Number1340818
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/14/2022
Initial Date FDA Received05/10/2022
Supplement Dates Manufacturer Received06/07/2022
Supplement Dates FDA Received06/10/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/06/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-